Patent details

Basic Information

Publication number:

EP3593814

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191858364

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODY FORMULATION

French Title of Invention:

FORMULATION D'ANTICORPS

German Title of Invention:

ANTIKÖRPERFORMULIERUNG

SPC Number:

Dates

Filing date:

11/06/2013

Grant date:

21/01/2026

EP Publication Date:

15/01/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/01/2026

EP B1 Publication Date:

21/01/2026

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/06/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/01/2026

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Stark, Christoph

Address:

Switzerland (CH)

2

Name:

Cosenza, Marta

Address:

Switzerland (CH)

Priority

Priority Number:

201261658472 P

Priority Date:

12/06/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61K 9/00; A61K 47/18; A61K 47/26; C07K 16/28; A61P 29/00; A61P 35/02;

Publication

European Patent Bulletin

1

Issue number:

202604

Publication date:

21/01/2026

Description:

Grant (B1)

2

Issue number:

202609

Publication date:

25/02/2026

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages